Cenra Inc. (TPE:3716)
33.75
-0.20 (-0.59%)
At close: Jan 20, 2026
Cenra Company Description
Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, self-care products for the prevention of diseases, home care and cosmetics, and animal healthcare products.
The company is also involved in the research and development, contracting manufacturing and international, and senior care services, as well as distributes and sells pharmaceutical brands.
In addition, it offers containers and plastic products. Cenra Inc. was founded in 1952 and is headquartered in Taipei, Taiwan.
Cenra Inc.
| Country | Taiwan |
| Founded | 1952 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 542 |
| CEO | Hou-Kai Wang |
Contact Details
Address: No. 23, Xiangyang Road Taipei, 10046 Taiwan | |
| Phone | 886 2 2312 4200 |
| Website | cenra.com |
Stock Details
| Ticker Symbol | 3716 |
| Exchange | Taiwan Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hou-Kai Wang | General Manager and Director |
| Chih-Yung Wu | President |
| Chao-Lang Lin | Director of Finance Department |
| Hui-Wen Hsiao | Accounting Supervisor |
| Te-Feng Chao | Director of Administrative Support Department |
| Teng-Pao Lin | Chief Auditor |
| Yin-Nan Sun | Vice President, Deputy GM and President of Chunghwa Yuming Healthcare Co Ltd |